Cambridge, United Kingdom

Rachid Lani

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 5.5

ph-index = 5

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Rachid Lani: Innovator in Peptide Ligand Technology

Introduction

Rachid Lani is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of peptide ligands, holding a total of six patents. His work focuses on the development of innovative polypeptides that have potential applications in treating diseases mediated by CD137.

Latest Patents

Lani's latest patents include groundbreaking inventions such as "Multimeric Bicyclic Peptide Ligands" and "Bicyclic Peptide Ligands Specific for CD137." The first patent describes multimers of polypeptides that are covalently bound to molecular scaffolds, allowing for the creation of high-affinity binders and activators of CD137. This invention also encompasses drug conjugates that can be used in pharmaceutical compositions for preventing, suppressing, or treating related diseases. The second patent further elaborates on polypeptides that are designed to bind specifically to CD137, enhancing their therapeutic potential.

Career Highlights

Throughout his career, Rachid Lani has worked with notable companies such as Bicycletx Limited and Bicyclerd Limited. His expertise in peptide technology has positioned him as a key figure in the development of innovative therapeutic solutions.

Collaborations

Lani has collaborated with talented individuals in his field, including Liuhong Chen and Kevin McDonnell. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Rachid Lani's work in peptide ligand technology showcases his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to developing effective treatments for diseases, particularly those mediated by CD137.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…